Suzhou Zelgen Biopharmaceuticals Co., Ltd. (SHA:688266)
99.42
-0.58 (-0.58%)
Apr 28, 2026, 3:00 PM CST
-1.35% (1Y)
| Market Cap | 26.32B |
| Revenue (ttm) | 810.48M |
| Net Income (ttm) | -162.95M |
| Shares Out | 264.71M |
| EPS (ttm) | -0.62 |
| PE Ratio | n/a |
| Forward PE | 47.49 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 3,093,634 |
| Average Volume | 3,305,537 |
| Open | 101.00 |
| Previous Close | 100.00 |
| Day's Range | 99.01 - 101.95 |
| 52-Week Range | 75.10 - 134.17 |
| Beta | -0.00 |
| RSI | 54.71 |
| Earnings Date | Apr 29, 2026 |